Vernalis Seeks Buyers, CEO To Step Down, As US Commercial Strategy Disappoints

Disappointing sales growth of its prescription extended-release cough-and-cold product has led Vernalis to decide to close down its US commercial operations, and to seek a buyer for the whole company.